Molecular characterization of antithrombin Barcelona-2: 47 arginine to cysteine.

[1]  C. Beresford.  Antithrombin III deficiency. , 1988, Blood reviews.

[2]  A. Stephens,et al.  Site-directed mutagenesis of the reactive center (serine 394) of antithrombin III. , 1988, The Journal of biological chemistry.

[3]  Jordi Félez,et al.  Quantitative and qualitative congenital deficiency of antithrombin III: A new molecular variant called at III - Barcelona 2 , 1988 .

[4]  H. Morris,et al.  Single amino acid substitutions in the reactive site of antithrombin leading to thrombosis. Congenital substitution of arginine 393 to cysteine in antithrombin Northwick Park and to histidine in antithrombin Glasgow. , 1988, The Journal of biological chemistry.

[5]  R. Carrell,et al.  Antithrombin Glasgow, 393 arg to his: A P1 reactive site variant with increased heparin affinity but no thrombin inhibitory activity , 1988, FEBS letters.

[6]  G. Cohen,et al.  Antithrombin III alger: A new case of Arg 47 ← cys mutation , 1987, American journal of hematology.

[7]  R. Carrell,et al.  SERPINS: ANTITHROMBIN AND OTHER INHIBITORS OF COAGULATION AND FIBRINOLYSIS. EVIDENCE FROM AMINO ACID SEQUENCES , 1987, Thrombosis and Haemostasis.

[8]  N. Duchange,et al.  Molecular characterization of the antithrombin III tours deficiency. , 1987, Thrombosis research.

[9]  T. Ono,et al.  Antithrombin III Toyama: replacement of arginine-47 by cysteine in hereditary abnormal antithrombin III that lacks heparin-binding ability. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[10]  B G Johansson,et al.  Agarose gel electrophoresis. , 1972, Scandinavian journal of clinical and laboratory investigation. Supplementum.

[11]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.